A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion
Clinical trial NCT03597009 · TERMINATED
Trial details
- NCT number
- NCT03597009
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-06
- Primary completion
- 2020-02-07
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.